Pediatrix Medical Group, Inc. (NYSE:MD) Shares Purchased by Boston Partners

Boston Partners boosted its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 25.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,956,353 shares of the company’s stock after acquiring an additional 393,600 shares during the quarter. Boston Partners owned 2.28% of Pediatrix Medical Group worth $25,922,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp boosted its holdings in Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after acquiring an additional 50,597 shares during the last quarter. Nordea Investment Management AB raised its position in Pediatrix Medical Group by 51.6% in the fourth quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock valued at $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC raised its position in Pediatrix Medical Group by 302.9% in the third quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after purchasing an additional 106,817 shares during the period. Franklin Resources Inc. purchased a new position in Pediatrix Medical Group in the third quarter valued at about $598,000. Finally, Principal Financial Group Inc. raised its position in Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after purchasing an additional 63,581 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Up 1.1 %

Shares of NYSE MD opened at $14.23 on Thursday. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of -11.86, a PEG ratio of 1.74 and a beta of 1.49. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock’s 50-day simple moving average is $14.25 and its 200-day simple moving average is $13.48.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Truist Financial raised their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. UBS Group raised their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, Macquarie began coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average price target of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.